Earl RA[au] - Search Results

Year	Number of Results
1966	1
1972	1
1979	1
1980	2
1988	1
1989	1
1990	1
1991	1
1992	1
1993	2
1996	1
1998	4
2000	1
2001	2
2002	1
2003	1
2004	2
2005	3
2021	1
2022	0

1

Nifedipine for primary dysmenorrhoea.

Earl RA, Grivell RM. Earl RA, et al. Cochrane Database Syst Rev. 2021 Dec 18;12(12):CD012912. doi: 10.1002/14651858.CD012912.pub2. Cochrane Database Syst Rev. 2021. PMID: 34921554 Review.

2

Assay methods for cyclosporine monitoring following liver transplantation.

Haven MC, Sobeski LM, Earl RA, Markin RS. Haven MC, et al. Among authors: earl ra. J Clin Lab Anal. 1990;4(2):150-6. doi: 10.1002/jcla.1860040214. J Clin Lab Anal. 1990. PMID: 2179503 Review.

3

3-(2-Methoxytetrahydrofuran-2-yl)pyrazoles: a novel class of potent, selective cyclooxygenase-2 (COX-2) inhibitors.

Ranatunge RR, Earl RA, Garvey DS, Janero DR, Letts LG, Martino AM, Murty MG, Richardson SK, Schwalb DJ, Young DV, Zemtseva IS. Ranatunge RR, et al. Among authors: earl ra. Bioorg Med Chem Lett. 2004 Dec 20;14(24):6049-52. doi: 10.1016/j.bmcl.2004.09.073. Bioorg Med Chem Lett. 2004. PMID: 15546727

4

Synthesis of certain [6:5:6] linear tricyclic nucleosides as potential antitumor agents.

Chung FL, Schram KH, Panzica RP, Earl RA, Wotring LL, Townsend LB. Chung FL, et al. Among authors: earl ra. J Med Chem. 1980 Nov;23(11):1158-66. doi: 10.1021/jm00185a002. J Med Chem. 1980. PMID: 7452664

5

Determination of 5-fluorouracil in human plasma by a simple and sensitive reversed-phase HPLC method.

Coe RA, Earl RA, Johnson TC, Lee JW. Coe RA, et al. Among authors: earl ra. J Pharm Biomed Anal. 1996 Sep;14(12):1733-41. doi: 10.1016/0731-7085(96)01832-8. J Pharm Biomed Anal. 1996. PMID: 8887721

6

MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products.

Duncia JV, Santella JB 3rd, Higley CA, Pitts WJ, Wityak J, Frietze WE, Rankin FW, Sun JH, Earl RA, Tabaka AC, Teleha CA, Blom KF, Favata MF, Manos EJ, Daulerio AJ, Stradley DA, Horiuchi K, Copeland RA, Scherle PA, Trzaskos JM, Magolda RL, Trainor GL, Wexler RR, Hobbs FW, Olson RE. Duncia JV, et al. Among authors: earl ra. Bioorg Med Chem Lett. 1998 Oct 20;8(20):2839-44. doi: 10.1016/s0960-894x(98)00522-8. Bioorg Med Chem Lett. 1998. PMID: 9873633

7

A proposed role for silicates and protein in the proliferative effects of saccharin on the male rat urothelium.

Cohen SM, Cano M, Earl RA, Carson SD, Garland EM. Cohen SM, et al. Among authors: earl ra. Carcinogenesis. 1991 Sep;12(9):1551-5. doi: 10.1093/carcin/12.9.1551. Carcinogenesis. 1991. PMID: 1893514

8

Identification of a novel inhibitor of mitogen-activated protein kinase kinase.

Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM. Favata MF, et al. Among authors: earl ra. J Biol Chem. 1998 Jul 17;273(29):18623-32. doi: 10.1074/jbc.273.29.18623. J Biol Chem. 1998. PMID: 9660836 Free article.

9

Two new potent neurotransmitter release enhancers, 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone and 10,10-bis(2-fluoro-4-pyridinylmethyl)-9(10H)-anthracenone: comparison to linopirdine.

Zaczek R, Chorvat RJ, Saye JA, Pierdomenico ME, Maciag CM, Logue AR, Fisher BN, Rominger DH, Earl RA. Zaczek R, et al. Among authors: earl ra. J Pharmacol Exp Ther. 1998 May;285(2):724-30. J Pharmacol Exp Ther. 1998. PMID: 9580619

10

Cytochrome c: ion binding and redox properties. Studies on ferri and ferro forms of horse, bovine, and tuna cytochrome c.

Gopal D, Wilson GS, Earl RA, Cusanovich MA. Gopal D, et al. Among authors: earl ra. J Biol Chem. 1988 Aug 25;263(24):11652-6. J Biol Chem. 1988. PMID: 2841331 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results